Monte Rosa Therapeutics's total assets for Q1 2024 were $266.75M, a decrease of -12.18% from the previous quarter. GLUE total liabilities were $114.23M for the fiscal quarter, a -8.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.